SADDLE RIVER, N.J.--(BUSINESS WIRE)--PDI, Inc. (NASDAQ: PDII), a pioneer in providing contract sales and commercial services to the biopharmaceutical industry, today announced the appointment of ...
PARSIPPANY, N.J., Dec. 22, 2015 /PRNewswire/ -- PDI, Inc.(PDII) today reported that as the Company transitions to focusing solely on its molecular diagnostics operations, Nancy Lurker has resigned as ...
PDI, Inc. (PDII) will visit the NASDAQ MarketSite in New York City's Times Square. In honor of the occasion, Nancy Lurker, Chief Executive Officer of PDI, Inc. (PDII), will preside over the NASDAQ ...
ORANGEBURG, N.Y., July 2, 2014 /PRNewswire/ -- Professional Disposables International, Inc., (PDI) announced the appointment of Peter Cempellin and Patrick Treacy to senior leadership roles that drive ...
“With PD One, pharmaceutical marketers have a new tool that bridges the gap between the direct sales model and digital marketing, creating an entirely new communication channel to more effectively ...
NEW YORK--(BUSINESS WIRE)--Prolias Technologies, Inc. has filed suit against PDI Inc. (NASDAQ: PDII), a New Jersey-based company. PDI Inc. is alleged to have engaged breach of contract, breach of ...
Parsippany-based health care commercialization company PDI Inc. announced Wednesday it has completed the sale of its commercial service business to Publicis Healthcare Communications Group for $25.5 ...
PARSIPPANY -- Speaking to more than 30 members of the Executive Women of New Jersey (EWNJ) on June 4, Nancy Lurker, CEO of Parsippany-based, PDI Inc. (NASDAQ: PDII), shared personal experiences and ...
Welcome to the PDI second quarter financial results conference call. At this time, all participants are in a listen-only mode. Following management's prepared remarks, we will hold a Q&A session.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results